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Background
There is an overlapping phenotype in patients with new-
onset systolic heart failure due to myocarditis and dilative
cardiomyopathy (DCM). Differentiation between both
etiologies has important therapeutic and prognostic
implications and is currently based on endomyocardial
biopsy (EMB). In contrast, current cardiovascular mag-
netic resonance (CMR) techniques are of limited value in
these patients with predominantly diffuse myocardial
injury. This study evaluated the performance of quantita-
tive T1- and T2-mapping CMR to differentiate between
active myocarditis and DCM in patients with new-onset
systolic heart failure.
Methods
This study included 26 patients with new-onset systolic
heart failure and reduced left ventricular (LV) ejection
fraction (32 ± 12 %), who underwent EMB and CMR at
1.5 Tesla. The protocol included conventional sequences
(T2w-STIR), Early- (T1w-TSE) and Late-Gadolinium-
Enhancement (PSIR). Furthermore, T1 quantification
was performed using the modified Look-Locker inversion-
recovery (MOLLI) sequence before (native) and 15 minutes
after administration of 0.075 mmol/kg Gadolinium-
BOPTA. T2 quantification was performed using a free-
breathing, navigator-gated multi-echo sequence. Native T1,
post-contrast T1, extracellular volume (ECV) and T2 maps
were calculated with a dedicated plug-in written for the
OsiriX software.
Results
EMB revealed variants of active myocarditis in 13 (50 %)
and DCM in the remaining 13 (50 %) patients. The ROC
areas-under-the-curve (AUC) to discriminate between
both etiologies was 0.54 (p = 0.77) for Early-Gadolinium-
Enhancement, 0.63 (p = 0.23) for Late-Gadolinium-
Enhancement, 0.68 (p = 0.11) for T2w-STIR, 0.66
(p = 0.17) for native global myocardial T1, 0.72 (p = 0.05)
for post-contrast global myocardial T1, 0.61 (p = 0.36) for
global myocardial ECV and 0.74 (p < 0.05) for global
myocardial T2. Sensitivity and specificity were 50 % and
83 % to discriminate between myocarditis and DCM using
global myocardial T2 (optimal cut-off ≥ 60 ms).
Conclusions
Assessing myocardial inflammation by T2-mapping CMR
could be helpful to discriminate between active myocardi-
tis and DCM in patients with new-onset systolic heart fail-
ure. T2-mapping CMR appears to be superior compared
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